Longevity & AgingWhy Male Mice Lose Anti-Cancer Immunity Earlier Than Females
Immune aging looks different in males and females, and it may help explain why men get more cancers as they reach middle age. A Massachusetts General Hospital study in Nature Aging implanted melanoma in young and middle-aged mice. Young males and females controlled tumors equally well, but middle-aged males did worse. The gap depended on CD8+ T cells, the immune cells that kill cancerous cells. Males lost their reserve of naive T cells, which have not yet met an antigen, earlier than females. Their lymph nodes also shrank sooner, leaving fewer distinct T cell receptors available to spot a tumor. Males also showed more virtual memory cells, which expand less well. Human blood datasets and CT scans pointed the same way, with smaller lymph nodes in men. Restoring thymic activity improved protection. The work is in mice, but it suggests a sex-specific, age-related immune decline that could shape future cancer prevention and immunotherapy.